Original Investigation

Nonregistration, Discontinuation, and Nonpublication of Randomized Trials

JAMA Network Open 10.1001/jamanetworkopen.2025.24440

September 03, 2025 at 9:00 AM EDT

Read the full article

What percentage of randomized clinical trials (RCTs) are unregistered, prematurely discontinued, or unpublished?This systematic review assessing 347 RCTs receiving ethical approval in 2016 in the UK, Switzerland, Germany, and Canada found that 5.8% were unregistered, 31.1% were discontinued (predominately because of poor recruitment), and 20.5% did not make results available. Industry-sponsored RCTs performed better than non–industry-sponsored RCTs in making trial results available (often through trial registries) and industry-sponsored RCTs were less likely to be discontinued due to poor recruitment.Results of this study suggest that actions are needed to improve good practice and transparency in RCTs, particularly among non–industry-sponsored trials.

Corresponding Author: Matthias Briel, CLEAR Methods Center, Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Totengässlein 3, 4051 Basel, Switzerland (matthias.briel@usb.ch).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.24440?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090325

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks